Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies

Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry

(2015) Pauline Bros et al.   Frontiers in Neuroscience

Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity

(2014) Kristen E. Funk et al.   BIOCHEMICAL JOURNAL

Quantification of Tau in Cerebrospinal Fluid by Immunoaffinity Enrichment and Tandem Mass Spectrometry

(2014) T. McAvoy et al.   CLINICAL CHEMISTRY

Direct analytical sample quality assessment for biomarker investigation: Qualifying cerebrospinal fluid samples

(2014) Viviana Greco et al.   PROTEOMICS

A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles

(2014) Sylvain Lehmann et al.   Alzheimers Research & Therapy

Diagnostic Performance of Cerebrospinal Fluid Total Tau and Phosphorylated Tau in Creutzfeldt-Jakob Disease

(2014) Tobias Skillbäck et al.   JAMA Neurology

Quantitative mass spectrometry (SRM/MRM) for amyloid peptides, tau protein and apolipoprotein E in human cerebrospinal fluid for Alzheimer's disease diagnosis

(2013) Sylvain Lehmann et al.   Alzheimers & Dementia

A New Decision Tree Combining Abeta 1-42 and p-Tau Levels in Alzheimer's Diagnosis

(2013) Stephanie Bombois et al.   Current Alzheimer Research

Alzheimer disease therapy—moving from amyloid-β to tau

(2013) Ezio Giacobini et al.   Nature Reviews Neurology

Biomarker Modeling of Alzheimer’s Disease

(2013) Clifford R. Jack et al.   NEURON

Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application

(2012) Sylvain Lehmann et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

PSAQ™ standards for accurate MS-based quantification of proteins: from the concept to biomedical applications

(2012) Guillaume Picard et al.   JOURNAL OF MASS SPECTROMETRY

Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies

(2012) Connie Luk et al.   JOURNAL OF NEUROCHEMISTRY

Selectivity of LC-MS/MS analysis: Implication for proteomics experiments

(2012) Sebastien Gallien et al.   Journal of Proteomics

Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics

(2012) Amelia C. Peterson et al.   MOLECULAR & CELLULAR PROTEOMICS

Mass spectrometry-based absolute protein quantification: PSAQ™ strategy makes use of “noncanonical” proteotypic peptides

(2012) Michel Jaquinod et al.   PROTEOMICS

Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology

(2011) Anne M. Fagan   ARCHIVES OF NEUROLOGY

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

(2011) N. S. M. Schoonenboom et al.   NEUROLOGY

Assay Development for the Determination of Phosphorylation Stoichiometry Using Multiple Reaction Monitoring Methods with and without Phosphatase Treatment: Application to Breast Cancer Signaling Pathways

(2010) Dominik Domanski et al.   ANALYTICAL CHEMISTRY

Transmission and spreading of tauopathy in transgenic mouse brain

(2009) Florence Clavaguera et al.   NATURE CELL BIOLOGY

Biochemistry of Tau in Alzheimer’s disease and related neurological disorders

(2008) Nicolas Sergeant et al.   Expert Review of Proteomics

Characterization of Tau in Cerebrospinal Fluid Using Mass Spectrometry

(2008) Erik Portelius et al.   JOURNAL OF PROTEOME RESEARCH